Log in to save to my catalogue

Serum Irisin Predicts Mortality Risk in Acute Heart Failure Patients

Serum Irisin Predicts Mortality Risk in Acute Heart Failure Patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1159_000477867

Serum Irisin Predicts Mortality Risk in Acute Heart Failure Patients

About this item

Full title

Serum Irisin Predicts Mortality Risk in Acute Heart Failure Patients

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Cellular physiology and biochemistry, 2017-01, Vol.42 (2), p.615-622

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Background/Aims: Irisin is a peptide hormone cleaved from a plasma membrane protein fibronectin type III domain containing protein 5 (FNDC5). Emerging studies have indicated association between serum irisin and many major chronic diseases including cardiovascular diseases. However, the role of serum irisin as a predictor for mortality risk in acute...

Alternative Titles

Full title

Serum Irisin Predicts Mortality Risk in Acute Heart Failure Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_citationtrail_10_1159_000477867

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1159_000477867

Other Identifiers

ISSN

1015-8987

E-ISSN

1421-9778

DOI

10.1159/000477867

How to access this item